RedHill Biopharma reported $584K in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 241K 649K Sep/2025
Cronos Group USD -18.33M 32.84M Sep/2025
RedHill Biopharma USD 584K 0 Jun/2024